Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriMix-DC vs TLR-DC in Melanoma
NCT01530698Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2010
- Primary completion
- Nov 2014
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TriMix-DC in melanoma, sponsored by Radboud University Medical Center. Started Apr 2010; status: completed.
02
Drugs
TriMix-DC
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01530698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530698.